Expansion into the dispensing pharmacy and drugstore businesses
First written in FY2022. 1 of 3 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025WorsenedAnnual report
「As the earnings initially expected could no longer be anticipated, the company recognized the entire unamortized balance of the goodwill as an impairment loss.」
In the pharmaceuticals-related business entered through making マックドラッグ a subsidiary, the earnings initially expected could no longer be anticipated, and the company recognized the full ¥25.803 million of goodwill as an impairment loss. - FY2023-Q1AdvancedAnnual report
「As 株式会社デリシア, a consolidated subsidiary of the company, acquired all shares of 株式会社マックドラッグ, マックドラッグ is now a consolidated subsidiary. Voting rights acquired: 100% Business combination date: 1 April 2022」
The company acquired all shares of マックドラッグ and made it a consolidated subsidiary, giving concrete form to its entry into the pharmaceuticals-related business. It also disclosed the objective of expanding the range of pharmaceuticals-related products handled at its retail stores and building a network of prescription pharmacies within the prefecture. - FY2022First statedAnnual report
「Effective 1 April 2022, the company made 株式会社マックドラッグ, which operates prescription pharmacies and drugstores, a subsidiary. As new businesses, the company will seek to expand stores handling OTC medicines and enter the prescription pharmacy business.」
Through making マックドラッグ a subsidiary, the company has positioned expanding stores handling OTC medicines and entering the prescription pharmacy business as new businesses.